← FDA DRUG APPROVALS

FDA ANDA · ANDA065281

DOXYCYCLINE HYCLATE

Sponsor: BAUSCH

APPLICATION
ANDA065281
TYPE
ANDA
ORIGINAL APPROVAL
2005-12-21
LATEST ACTION
2015-12-21
ROUTE
ORAL
DOSAGE FORM
CAPSULE, DELAYED RELEASE
MARKETING STATUS
Discontinued

Products

DOXYCYCLINE HYCLATEDiscontinued
DOXYCYCLINE HYCLATE EQ 75MG BASE · CAPSULE, DELAYED RELEASE · ORAL
DOXYCYCLINE HYCLATEDiscontinued
DOXYCYCLINE HYCLATE EQ 100MG BASE · CAPSULE, DELAYED RELEASE · ORAL

Approval history

2015-12-21Labeling · Supplement 2AP
2005-12-21OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →